The Transplant Team
Transplantation is a complex, long-term process of which the actual surgery is only one element. To address every aspect of the many interrelated issues, a multidisciplinary team of experts becomes involved at the earliest pre-operative evaluation and remains involved throughout hospitalization and follow-up.In addition to both medical and surgical specialists in the specific transplant areas, the team includes carefully selected experts from a wide range of areas:
- Infectious Disease
- Social Services
- Physical Therapy
- Financial Services
Additional consultants, as indicated by medical condition or coexisting diseases, are immediately available and are called in as necessary. We see transplant candidates as patients and as people with a broad range of specific needs that must be addressed for the transplant to be successful.
Stephen T. Bartlett, M.D.
Stephen T. Bartlett arrived at the University of Maryland in 1991. He is chairman of the Department of Surgery at the University of Maryland School of Medicine, surgeon-in-chief and senior vice president at the University of Maryland Medical System, and the Peter Angelos Distinguished Professor.
Dr. Bartlett received his medical degree from the University of Chicago and spent his residency at the University of Pennsylvania. He continued his training at Northwestern University and then became an associate professor at the University of California Davis before coming to Maryland to build the university's Transplant Program. His specialties include kidney and pancreas transplantation and vascular surgery.
Eugene J. Schweitzer, M.D.
Eugene J. Schweitzer arrived at the University of Maryland in 1991. He received his medical degree from University of Medicine and Dentistry of New Jersey and spent his residency at University Hospital, Newark. He continued his training at the University of Minnesota and became an assistant professor at Georgetown.
Dr. Schweitzer specializes in kidney and pancreas transplantation and plays an active role in clinical research.
Jonathan Bromberg, M.D., Ph.D.
Jonathan Bromberg, M.D., Ph.D., is the chief of the Division of Transplantation. A renowned kidney and pancreas transplant surgeon who specializes in research relating to immunology, Dr. Bromberg comes to Baltimore after more than a decade at Mount Sinai School of Medicine in New York. Dr. Bromberg received both his M.D. and Ph.D. from Harvard Medical School and completed a surgical residency at the University of Washington. His training continued with a transplantation fellowship at the University of Pennsylvania. At Maryland, Dr. Bromberg serves as the director for research in the Division of Transplantation and director of strategic services for transplantation.
Best known for his innovative research involving immunosuppressive therapies, Dr. Bromberg has devoted his career to investigating the role of immunology in transplantation, with a current focus on the effects of chemokines and cell migration on the immune response.
Rolf Barth, M.D.
Rolf Barth is an associate professor of surgery at the University of Maryland School of Medicine and the director of liver transplantation at UM Medical Center. His clinical practice focuses on kidney, pancreas, and liver transplantation. Dr. Barth also performs minimally invasive surgery for living kidney donation and performed the first "scarless" single-port laparoscopic donor nephrectomies in Maryland. Dr. Barth and colleagues also offer robotic laparoscopic surgical approaches for complicated hepatobiliary disease.
Dr. Barth received his medical degree and surgical training at Duke University and continued specialty training in transplant surgery at University of Wisconsin-Madison. Dr. Barth also performed post-doctoral training in transplant immunology at Massachusetts General Hospital/Harvard Medical School. Dr. Barth has active clinical and basic research interests that include novel immunosuppressive therapies, immunologic tolerance, and the use of genetically engineered animal organs for human transplantation (xenotransplantation). Dr. Barth, along with Dr. Eduardo Rodriguez in plastic and reconstructive surgery and Dr. Stephen Bartlett, have an active lab investigating transplant tolerance and pre-clinical models of composite facial and limb transplantation towards the clinical goal of reconstructive transplantation. These efforts recently resulted in the most-extensive face transplant performed worldwide to date.
Steven I. Hanish, M.D.
Dr. Steven Hanish is an Associate Professor of Surgery at the University of Maryland School of Medicine and director of hepatobiliary surgery at the University of Maryland Medical Center. He received his medical degree from the Indiana University School of Medicine and completed his general surgery residency at Duke University Medical Center. Dr. Hanish then completed a multi-visceral abdominal transplant fellowship at the University of Wisconsin. In 2009, he was recruited to Emory University Hospital where he served as both a liver transplant and hepatobiliary surgeron and director of the multidisciplinary liver tumor board.
Dr. Hanish specializes in Liver Transplantation and Hepatobiliary Surgery, as well as both kidney and pancreas transplantation. He has expertise in the surgical management of both primary and metastatic disease to the liver. He has a special interest in Cholangiocarcinoma and received subspecialty training in laparascopic liver resection.
Dr. Hanish's research interest focuses on outcomes of liver transplant recipients and those patients with primary hepatic malignancies and the use of MRI in the diagnosis of liver tumors, both benign and malignant. Moreover, he has been active on both the national and local levels in increasing organ donation and process optimization to improve patient outcomes.
John C. LaMattina, M.D.
Dr. LaMattina is an assistant professor of surgery at the University of Maryland School of Medicine and director of the living donor liver transplant program at the University of Maryland Medical Center. He received his medical degree from Harvard Medical School and completed his general surgical residency at Massachusetts General Hospital/Harvard Medical School. Following residency, he obtained subspecialty training in transplant surgery at the University of Wisconsin. After completing his fellowship, Dr. LaMattina acquired additional training in living-donor liver transplant surgery at Memorial Hospital in Istanbul, Turkey.
Dr. LaMattina specializes in kidney, pancreas, and liver transplantation. He is particularly interested in Living Donor Liver transplantation, and performs minimally invasive surgery for living kidney donation.
In conjunction with his colleagues Dr. Rolf Barth and Dr. Richard Pierson, Dr. LaMattina is investigating mechanisms responsible for coagulopathy following liver xenotransplantation in a preclinical model.
David B. Leeser, M.D., F.A.C.S.
Dr. Leeser is an associate professor of surgery at the University of Maryland School of Medicine and Chief of Kidney and Pancreas Transplantation and Director of the Fellowship in Transplantation at the University of Maryland Medical Center. He received his medical degree from Temple University School of Medicine and completed his general surgical residency at Temple University.
Following residency, he completed a fellowship in transplant surgery at the University of Maryland Medical Center. After completing his fellowship, Dr. Leeser served in the United States Army. During his time in the service, Dr. Leeser was deployed twice in support of operation Iraqi Freedom and became the Director of Kidney and Pancreas Transplantation at the Walter Reed Army Medical Center. Prior to retiring from the Army, Dr. Leeser rose to the rank of Lieutenant Colonel and was awarded the Bronze Star for his service in Iraq while running a combat support hospital. After leaving the Army, he served as assistant professor of surgery at Weill-Cornell Medical College and the Director of Pancreas Transplantation at New York-Presbyterian Hospital Weill-Cornell Medical Center in Manhattan. Dr. Leeser has special interests in research pertaining to hemodialysis access and surgical education.
Dr. Leeser specializes in kidney and pancreas transplantation, single port donor nephrectomy, and minimally invasive hemodialysis access surgery. Dr. Leeser has been named to the 2012 Super Docs and to the Best Doctors 2010-2012 in New York City.
Silke V. Niederhaus, M.D.
Silke Niederhaus is a clinical assistant professor of surgery at the University of Maryland School of Medicine. She received her medical degree from University of Alabama School of Medicine and completed her surgical residency and a two-year research fellowship at the University of Wisconsin. Following residency, Dr. Niederhaus completed two years of sub-specialty training in abdominal transplantation, also at the University of Wisconsin.
Dr. Niederhaus specializes in kidney and pancreas transplantation, laparoscopic and single-port donor nephrectomy, and liver transplantation. Dr. Niederhaus has a number of papers and abstracts published, many centering on organ transplants and organ donors and recipients. Dr. Niederhaus received a kidney transplant herself more than 20 years ago and therefore brings a unique perspective to the field of transplantation and immunosuppression management.
Helen Han, M.D.
Dr. Han is an Assistant Professor of Medicine at the University of Maryland School of Medicine.
Dr. Han received her undergraduate degree from Columbia University in New York City and her medical degree from the University of Miami Miller School of Medicine in Miami, Florida. She completed her postgraduate training in Internal Medicine as well as her fellowships in Gastroenterology and Transplant Hepatology at Mount Sinai Hospital in New York, NY.
Dr. Han’s clinical interests include chronic liver diseases, particularly hepatitis B and C, PSC in IBD patients, and global health. Her research interests include understanding health disparities in minority communities, issues of quality improvement, and medical education.
William R. Hutson, M.D.
Dr. Hutson is a professor of medicine and Director of Hepatology and Medical Director of Liver Transplantation in the Division of Gastroenterology and Hepatology at the University of Maryland Medical Center.
Dr. Hutson received his medical degree from West Virginia University and completed a residency in internal medicine at the same institution. Dr. Hutson subsequently completed a fellowship in gastroenterology and hepatology at the University of Pittsburgh Medical Center. Upon completion of his fellowship he joined the faculty at the University of Utah Health Sciences Center as an assistant professor of medicine. Later he returned to the University of Pittsburgh Medical Center and became a faculty member in the Divisions of Gastroenterology and Hepatology and Transplantation Medicine. He assumed the role of Medical Director of the Small Intestinal Transplantation program, and as a member of the internationally acclaimed Thomas E. Starzl Transplant Institute. The Small Intestinal Transplantation program was recognized worldwide for its ground breaking clinical and research accomplishments. Following his tenure at UPMC, Dr. Hutson returned to the University of Utah Medical Center and Huntsman Cancer Institute where he established a new liver transplant program, and assumed the roles of Director of Liver Transplantation and Director of Hepatology.
As an accomplished researcher and clinician, Dr. Hutson has published numerous articles and book chapters, and lectured extensively. His special interests are in the areas of liver transplantation, liver diseases, and hepatic malignancy. Dr. Hutson will be actively involved in directing the liver transplant program and the hepatology program at the University of Maryland Medical Center.
Charles D. Howell, M.D.
Dr. Howell is a professor of medicine at the University of Maryland School of Medicine. He received his medical degree from Howard University and completed his residency training in internal medicine at Baylor College of Medicine. He went on to complete fellowship training in gastroenterology at University of Colorado Health Sciences Center.
Dr. Howell's clinical interests include management of chronic liver diseases, particularly hepatitis B and C, primary biliary cirrhosis and autoimmune hepatitis. He has three main research interests: 1) understanding the pathogenesis of liver injury due to chronic hepatitis C, 2) studying host genes and cellular pathways that mediate HCV clearance spontaneously and during interferon and ribavirin therapy; and 3) racial disparities in hepatitis C and primary hepatocellular carcinoma.
Dr. Howell was chair of the Steering Committee and principal investigator for the Baltimore site of the NIDDK Study of Viral Resistance to Antiviral Therapy for Chronic Hepatitis C (VIRAHEP-C) (2001-2006). In addition, he is a recipient of a RO1 award (2004-2007) titled "Predicting the Outcomes of Hepatitis C Treatments."
Sandeep Khurana, M.B.B.S.
Dr. Khurana is an assistant professor of medicine at the University of Maryland School of Medicine and the Clinical Director of Hepatology in the Division of Gastroenterology and Hepatology at the University of Maryland Medical Center.
He received his medical degree from University College in New Delhi, India, He completed his residency in internal medicine at State University of New York, Brooklyn and went on to complete his fellowship training in gastroenterology at University of Arkansas for Medical Sciences. Dr. Khurana's special interests include liver diseases, especially portal hypertension and hemodynamic changes associated with cirrhosis, and bile acid effect on vaculature.
Dr. Khurana's research is focused on signaling mechanisms of hemodynamic changes associated with cirrhosis, and he is. Dr. Khurana is specifically interested in elucidating the role of bile acids in mediating these vascular changes.
Ayse L. Mindikoglu, M.D., M.P.H.
Dr. Mindikoglu is an assistant professor of medicine at the University of Maryland School of Medicine. She received her medical degree from University of Istanbul, Cerrahpasa Faculty of Medicine and completed her residency training in general surgery at University of Istanbul, Cerrahpasa Faculty of Medicine, as well as internal medicine at Bronx-Lebanon Hospital Center in New York.
She went on to complete her fellowship training in gastroenterology at Loyola University Medical Center, and in hepatology at University of Miami Leonard M. Miller School of Medicine.
Dr. Mindikoglu's clinical interests are cirrhosis and its complications (e.g. acute kidney injury, ascites, encephalopathy, hepatocellular carcinoma), viral hepatitis, drug-induced hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, liver diseases in pregnancy and liver transplantation. Her current research is focused on outcomes of patients on the liver transplant waiting list and after liver transplantation. Her prior research involved coagulation and fibrinolysis in patients with advanced liver disease, non-alcoholic fatty liver disease and metabolic syndrome on progression of fibrosis in patients with recurrent hepatitis C after liver transplantation.
Darryn R. Potosky, M.D.
Dr. Potosky is a board certified gastroenterologist and hepatologist in the Division of Gastroenterology and Hepatology at the University of Maryland Medical Center and an assistant professor of medicine at the University of Maryland School of Medicine.
Dr. Potosky received his undergraduate degree from the University of Maryland College Park, and his medical degree from the University of Maryland School of Medicine in Baltimore, Maryland. He completed his postgraduate training in internal medicine at the University of Maryland and Baltimore VA Medical Centers where he was chosen as Chief Resident. He performed his gastroenterology and hepatology fellowship also at the University of Maryland and Baltimore VA Medical Centers. In addition, Dr. Potosky has completed a one-year fellowship at the University of Maryland in Transplant Hepatology, focusing on the care of patients in and around the time of liver transplantation.
Specialists in each area provide the expertise vital to successful transplantation. Having spent their careers studying, treating and understanding the functioning of the specific organ, as well as the network of subtle interactions between the organ and the rest of the body, these physicians are able to precisely assess the evolving condition of the patient.
During long-term follow-up, the specialists closely monitor the patient's progress and help determine an individualized medication program. They make careful assessments of the body's reaction to the transplant and monitor and adjust the anti-rejection medications that truly make the transplant viable.
The excellence and specialized focus of our surgical staff is supplemented by the comprehensive expertise of nurse coordinators who provide 24-hour, 365-day-a-year support for the program.
From initial screening through in-hospital preparation and education, and during the extended period of follow-up care, nurse coordinators provide treatment, information and most importantly, close personal support. At any time, patients and their families can speak with someone who knows, someone who cares and someone who can help immediately regardless of the issue or problem.
We believe that the deep personal bonds that develop between coordinators and patients are essential to our work and crucial to the overall success of the program.
To speak with someone about our services, please call 1-410-328-5408 or 1-800-492-5538.
This page was last updated: August 14, 2013